Servizi e Laboratori » Centro per lo studio della Malattia di Alzheimer e demenze correlate » Pubblicazioni


Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, Baron PL, Lipton JM, Catania A. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. Journal of Leukocyte Biology 1998;63:740-745.

Galimberti D, Baron PL, Meda L, Prat E, Scarpini E, Delgado R, Catania A, Lipton JM, Scarlato G.
a-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-a by microglial cells activated with b-amyloid and interferon-g. Biochemical and Biophysical Research Communications 1999;263:251-256.

Prat E, Baron P, Meda L, Scarpini E, Galimberti D, Ardolino G, Catania A, Scarlato G. The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP-1) upon stimulation with b-amyloid protein. Neuroscience Letters 2000;283:177-180.

Baron PL, Galimberti D, Meda L, Prat E, Scarpini E, Conti G, Moggio M, Prelle A, Scarlato G. Synergistic effect of b-amyloid protein and Interferon-g or nitric oxide production by C2C12 muscle cells. Brain 2000;123:374-379.

Baron P, Galimberti D, Meda L, Scarpini E, Conti G, Cogiamanian F, Scarlato G. Production of IL-6 by human myoblasts stimulated with Ab: relevance in the pathogenesis of IBM. Neurology 2001;57:1561-1565.

Rigamonti AE, Pincelli AI, Corrà B, Viarengo R, Bonomo SM, Galimberti D, Scacchi M, Scarpini E, Cavagnini F, Müller EE. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. Journal  of Endocrinology 2002;175:R1-5.

Galimberti D, Schoonenboom N, Scarpini E, Scheltens P, on behalf of the DIAR Group. Chemokines in CSF and serum from patients with different types of dementia. Annals of Neurology 2003; 53: 547-548.

Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, Tiriticco M, Mariani C, Forloni G, Pettenati C, Baron PL, Conti G, Bresolin N, Scarpini E. MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiology of Aging 2004;25(9):1169-1173.

Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Venturelli E, Cutter GR, Mariani C, Forloni G, Pettenati C, Baron PL, Conti G, Bresolin N, Scarpini E. CCR2-64I polymorphism and CCR5∆32 deletion in patients with Alzheimer’s disease. Journal of the Neurological Sciences 2004; 225: 79-83.

Guidi I, Galimberti D, Venturelli E, Lovati C, Del Bo R, Fenoglio C, Gatti A, Dominici R, Galbiati S, Virgilio R, Pomati S, Comi GP,Mariani C, Forloni G, Bresolin N, Scarpini E. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients. Neurobiology of Aging, 2005; 26(6): 789-794.

Del Bo R, Scarlato, M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP. VEGF gene variability is associated with increased risk of Alzheimer’s disease. Annals of Neurology, 2005; 57: 373-78

Venturelli E, Galimberti D, Lovati C, Fenoglio C, Mariani C, Forloni G, Bresolin N, Scarpini E. The T-786C NOS3 polymorphism in Alzheimer’s disease: association and influence on gene expression. Neuroscience Letters 2005; 382: 300-303.

Galimberti D, Venturelli E, Gatti A, Lovati C, Fenoglio C, Mariani C, Forloni G, Bresolin N, Scarpini E. Association of neuronal Nitric Oxide Synthase C276T polymorphism with Alzheimer’s disease. Journal of Neurology 2005; 252: 985-986.
Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Archives of Neurology 2005;62(11):1728-33.
Baron P, Bussini S, Cardin V, Corbo M, Conti G, Galimberti D, Scarpini E, Bresolin N, Wharton SB, Shaw PJ, Silani V. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 2005; 32(4): 541-544.

Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M, Fenoglio C, Venturelli E, Baron PL, Bresolin N, Scarpini E. Oxidative imbalance in patients with Mild Cognitive Impairment and Alzheimer's  disease. Neurobiology of Aging 2006;27(2):262-269.

Del Bo, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, Galbiati S, Virgilio R, Galimberti D, Ferrarese C, Scarpini E, Bresolin N, Comi GP. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiology of Aging 2006;27(5):770.

Scarpini E, Galimberti D, Guidi I, Bresolin N, Scheltens P. Progressive, isolated language disturbance: its significance in a 65-year-old-man. A case report with implications for treatment and review of literature. Journal of the Neurological Sciences 2006;240:45-51.

Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg YAL, Bresolin N, Scarpini E. Intrathecal chemokine levels in Alzheimer’s disease and Frontotemporal Lobar degeneration. Neurology 2006; 66(1):146-147.

Saltini G, Dominici R, Lovati C, Cattaneo M, Michelini S, Malferrari G, Caprera A, Milanesi L, Finazzi D, Bertora P,Scarpini E, Galimberti D, Venturelli E, Musicco M, Adorni F, Mariani C, Biunno I. A novel polymorphism in SEL1L confers susceptibility to Alzheimer’s disease. Neuroscience Letters 2006;398(1-2):53-8.

Pesaresi M, Lovati C, Bertora P, Mailland E, Galimberti D, Scarpini E, Quadri P, Forloni G, Mariani C. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging 2006; 27: 904-905.

Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Bresolin N, Scarpini E. Serum MCP-1 levels are increased in Mild Cognitive Impairment and mild Alzheimer's disease. Neurobiology of Aging 2006; 27: 1763-1768.

Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E. Intrathecal chemokine synthesis in Mild Cognitive Impairment and Alzheimer's disease. Archives of Neurology 2006;63:538-543.

E. Scarpini, D. Galimberti, N. Bresolin.Genetics and neurobiology of Frontotemporal Lobar Degeneration. Neurological Sciences 2006, 27 Suppl.1: S32-S34.

Giunta M, Rigamonti AE, Scarpini E, Galimberti D, Bonomo SM, Venturelli E, Müller EE, Cella SG. The leukocyte expression of CD36 is low in patients with Alzheimer’s disease and Mild Cognitive Impairment. Neurobiology of Aging 2007, 28(4):515-518.

Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Forloni G, Bresolin N, Scarpini E. Candidate gene analysis of  IP-10 gene in patients with Alzheimer's disease. Neuroscience Letters 2006 ; 404: 217-221.

Fenoglio C, Galimberti D, Piccio L, Scalabrini D, Panina P, Buonsanti C, Venturelli E, Lovati C, Baron P, Forloni G, Mariani C, Bresolin N, Scarpini E.Absence of polymorphisms in TREM-2 coding region in patients with early onset dementia. Neuroscience letters 2007; 411: 133-137.

Albani D, Batelli S, Prato F, Pesaresi M, Galimberti D, Scarpini E, Bruni A, Franceschi M, Piras MR, Confaloni A, Roiter I, Artuso V, Forloni G. Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population. Neurobiology of Aging 2007, 28(11):1682-1688.

Galimberti D, Venturelli E, Fenoglio C, Lovati C, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Bresolin N, Scarpini E. IP-10 serum levels in Mild Cognitive Impairment and Alzheimer’s disease. European Journal of neurology, 2007; 14: e3-e4.

Galimberti D, Scarpini E, Venturelli E, Strobel A, Herterichc S, Fenoglio C, Guidi I, Scalabrini D, Cortini F, Bresolin N, Lesch KP, Reif A. Association of a NOS1 promoter repeat with Alzheimer’s disease. Neurobiology of Aging 2008; 29(9): 1359-1365.

Poli M, Gatta LB, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I, Musicco M, Dominici R, Albertini A, Finazzi D. Interaction between the APOE varepsilon4 allele and the APH-1b c+651T>G SNP in Alzheimer's disease. Neurobiology of Aging 2008; 29(10):1494-1501.

Lovati C, Galimberti D, Pomati S, Capiluppi E, Dolci A, Scapellato L, Rosa S, Mailland E, Suardelli M, Vanotti A, Clerici F, Santarato D, Panteghini M, Scarpini E, Mariani C, Bertora P. Serum folate concentrations in patients with cortical and subcortical dementia. Neuroscience Letters 2007; 420(3):213-216.

Del Bo R, Ghezzi S, Scarlato M, Albani D, Galimberti D, Lucca U, Tettamanti M, Scarpini E, Forloni G, Bresolin N, Comi GP. Role of VEGF gene variability in longevity: A lesson from the Italian population. Neurobiology of Aging 2007 Jun 13; [Epub ahead of print]

Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007;6(6):501-12.

Bonomo SM, Rigamonti AE, Giunta M, Galimberti D, Guaita A, Gagliano MG, Muller EE, Cella SG. Menopausal transition: A possible risk factor for brain pathologic events. Neurobiol Aging 2007 Jun 29; [Epub ahead of print] 

Pesaresi M, Batelli S, Prato F, Polito L, Lovati C, Scarpini E, Quadri P, Mariani C, Albani D, Forloni G.The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level. Neurobiol Dis 2007;25(3):609-13.

Arosio B, Bergamaschini L, Galimberti L, La Porta C, Zanetti M, Calabresi C, Scarpini E, Annoni G, Vergani C. +10 T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution. Mech Ageing Dev 2007;128(10):553-7.

Bersano A, Del Bo R, Lamperti C, Ghezzi S, Fagiolari G, Fortunato F, Ballabio E, Moggio M, Candelise L, Galimberti D, Virgilio R, Lanfranconi S, Torrente Y, Carpo M, Bresolin N, Comi GP, Corti S. Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiology of Aging 2007 Sep 22; [Epub ahead of print].

Galimberti D, Venturelli E, Fenoglio C, Guidi I, Villa C, Bergamaschini L, Cortini F, Scalabrini D, Baron P, Vergani C, Bresolin N, Scarpini E. Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer’s disease and Frontotemporal Lobar Degeneration. Journal of Neurology 2008; 255(4): 539-544.

Venturelli E, Villa C, Scarpini E, Fenoglio C, Guidi I, Lovati C, Marcone A, Cortini F, Scalabrini D, Clerici F, Bresolin N, Mariani C, Cappa S, Galimberti D. Neuronal Nitric Oxide Synthase C276T polymorphism increases the risk for Frontotemporal Lobar Degeneration. European Journal of Neurology 2008; 15: 77-81.

Galimberti D, Fenoglio C, Scarpini E. Inflammation in neurodegenerative disorders: friend or foe? Current Aging Science 2008; 1: 30-41.

Reif A, Scarpini E, Venturelli E, Töpner T, Fenoglio C, Lesch KP, Galimberti D. The functional MAOA-uVNTR promoter polymorphism in patients with frontotemporal dementia. European Journal of Neurology 2008;15(6):637-639.

Borroni B, Archetti S, Alberici A, Agosti C, Gennarelli M, Bigni B, Bonvicini C, Ferrari M, Bellelli G, Galimberti D, Scarpini E, Di Lorenzo D, Caimi L, Caltagirone C, Di Luca M, Padovani A. Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. Neurogenetics 2008;9(3):197-205.

Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition. Proceedings of the National Academy of Sciences USA 2008;105(23):8050-8054.

Dreses-Werringloer U, Lambert J, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett KJ, Campagne F, Marambaud P. A polymorphism in CALHM1 influences Ca2+ homeostasis, Ab levels, and Alzheimer’s disease risk. Cell 2008; 133: 1-13.

Benerini Gatta L, Vitali M, Zanola A, Venturelli E, Fenoglio C, Galimberti D, Scarpini E, Finazzi D. Polymorphisms in the LOC387715/ARMS2 Putative Gene and the Risk for Alzheimer's Disease. Dement Geriatr Cogn Disord 2008;26(2):169-174.

Borroni B, Ghezzi S, Agosti C, Archetti S, Fenoglio C, Galimberti D, Scarpini E, Di Luca M, Bresolin N, Comi GP, Padovani A, Del Bo R. Preliminary Evidence that VEGF Genetic Variability Confers Susceptibility to Frontotemporal Lobar Degeneration. Rejuvenation Research 2008;11(4):773-780.

Cortini F, Fenoglio C, Guidi I, Venturelli E, Pomati S, Marcone A, Scalabrini D, Villa C, Clerici F, Dalla Valle E, Mariani C, Cappa S, Bresolin N, Scarpini E, Galimberti D. Novel exon 1 progranulin gene variant in Alzheimer's disease. European Journal of Neurology 2008, 15: 1111–1117.

Ferrucci R, Mameli F, Guidi I, Mrakic-Sposta S, Vergari M, Marceglia S, Cogiamanian F, Barbieri S, Scarpini E, Priori A.Transcranial direct current stimulation improves recognition memory in Alzheimer disease. Neurology 2008;71(7):493-8.

Maggi S, Noale M, Zambon A, Limongi F, Romanato G, Crepaldi G; ILSA Working Group.
Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population: the Italian Longitudinal Study on Aging. Atherosclerosis 2008;197(2):877-82.

CAPITOLI IN VOLUMI INTERNAZIONALI

Galimberti D, Fenoglio C, Scarpini E. Immunological Aspects in Neurodegenerative Disorders. In: “Neuroimmunology Research Focus” 2007: 5-42. Novapublishers, New York, USA (Editor: Paulo V. Broglio).

Galimberti D, Scarpini E. Role of chemokines in neurodegeneration. In: “Progress in chemokine research” 2007: 141-147. Novapublishers, New York, USA (Editor: WP Linkes).

Galimberti D, Fenoglio C, Scarpini E. Early onset dementia: role of genetics in the pathogenesis of Alzheimer’s disease and Frontotemporal Lobar Degeneration. In: “Alzheimer Disease in the Middle-Aged”, in press. Novapublishers, New York, USA (Editor: Frank Columbus)

Galimberti D, Fenoglio C, Scarpini E. Alzheimer’s disease: from pathogenesis to new perspectives for treatment. In: “A Multidisciplinary Approach to Dissect the Alzheimer’s Pathology” 2008: 111-129. Transworld Research Network, 37/661 (2), Fort P.O., Trivandrum-695 023, Kerala, India (Editors: Roberto Dominici and Ida Biunno)